Mirabegron Impurity 53 | CAS 53266-94-7 - Request Quote
Mirabegron Impurity 53
| SZ CAT No: | SZ-M035070 |
| CAS No | 53266-94-7 |
| Mol.F. | C7H10N2O2S |
| Mol.Wt. | 186.2 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 76629-17-9 (HCl salt) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Mirabegron Impurity 53 is chemically Ethyl 2-(2-aminothiazol-4-yl)acetate. Mirabegron Impurity 53 is supplied with detailed characterization data compliant with regulatory guideline. Mirabegron Impurity 53 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mirabegron.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 53266-94-7
Purchase 53266-94-7
Order 53266-94-7
Enquire 53266-94-7
price of 53266-94-7
53266-94-7 Supplier
53266-94-7 Manufacturer
53266-94-7 Exporter
buy high quality Mirabegron Impurity 53
Purchase Mirabegron Impurity 53
Mirabegron Impurity 53 suppliers
Mirabegron Impurity 53 manufacturers
Mirabegron Impurity 53 price
Order Mirabegron Impurity 53
Enquire Mirabegron Impurity 53
Mirabegron Impurity 53 cost
Mirabegron Impurity 53 Supplier
Mirabegron Impurity 53 Distributor
Mirabegron Impurity 53 for Method Validation
Mirabegron Reference Standard
Mirabegron Impurity 53 for ANDA Filing
Mirabegron Impurity 53 for Forced Degradation Studies
Mirabegron Impurity 53 Identification Standards
Mirabegron Impurity 53 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.